Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Cyagen logo — Using proven methods to bring your custom model idea to life...

Cyagen

Using proven methods to bring your custom model idea to life.

Founded 2005 United States Santa Clara, United States 113 employees Series B Total: $41.00M Biotechnology, Manufacturing +1

General Information

Company Name Cyagen
Founded Year 2005
Location United States Santa Clara, United States
Employees 113
Industries Biotechnology, Manufacturing, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Cyagen. To contact Cyagen, visit cyagen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cyagen compare?

A PDF of Cyagen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cyagen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cyagen

Cyagen is a 900-employee company headquartered in Santa Clara, California, with additional locations in Germany, Japan, and China. The company's slogan, "Using proven methods to bring your custom model idea to life," encapsulates its mission to provide tailored solutions for biomedical scientists' gene research needs. As the world's largest provider of custom-engineered mouse and rat models, Cyagen offers comprehensive services ranging from DNA vector construction to breeding, characterized by flexibility, top quality, full guarantees, and competitive prices. Moreover, Cyagen provides Contract Research Organization (CRO) services for cell and gene therapy (CGT) research, covering viral vector development, CAR design and construction, disease models, phenotype analysis, and pharmacodynamic evaluations. The company also offers a wide range of stem cell products for research use, including cell lines, media, and differentiation kits. With an array of services that cater to the growing demands of the biomedical research sector, Cyagen presents a compelling opportunity for venture capital firms seeking to invest in the burgeoning field of genetic research and biotechnology. The company's multi-location presence, commitment to quality, and diverse product offerings position it as an attractive prospect for potential investors looking to tap into the rapidly expanding life sciences market.

Business keywords: Biomedical research, Genetic engineering, Mouse models, Rat models, Gene therapy, Custom model generation, Stem cell products, Cell and gene therapy research, Contract Research Organization, Viral vector development, CAR design, Phenotype analysis, Pharmacodynamic evaluations, Biotechnology services, DNA vector construction

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $41.00M 4
GF Qianhe Investment GF Xinde
GF Qianhe Investment, GF Xinde +2
26 Feb 2020

Cyagen Alternatives & Competitors

View All Alternatives
Cyagen vs
ProBio
ProBio United States

Manufacturing Life-Changing Therapies

Series C
246 employees
Biopharma, Biotechnology
Cyagen vs
Anjarium Biosciences AG
Anjarium Biosciences AG Switzerland

DNA to Catalyze Your Advanced Therapies

Series A
15 employees
Biotechnology, Pharmaceutical
Cyagen vs
Dyno Therapeutics
Dyno Therapeutics United States

We build AI-powered gene therapies.

Series A
94 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About Cyagen

Using proven methods to bring your custom model idea to life.
Cyagen was founded in 2005.
Cyagen is headquartered in Santa Clara, United States.
Cyagen operates in Biotechnology, Manufacturing and Pharmaceutical. Its work centres on Biomedical research, Genetic engineering, Mouse models and Rat models.
Cyagen has approximately 113 employees.
Cyagen has completed 1 funding round, raising a total of $41.00M. The latest funding stage is Series B.
Top alternatives and competitors to Cyagen include ProBio, Anjarium Biosciences AG, Dyno Therapeutics, Alpha Genesis Inc., 3D Genomics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cyagen and ProBio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cyagen, https://bouncewatch.com/company/cyagen, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes